Table 4.

The clinicopathologic characteristics and IDO expression in mature T- and NK-cell neoplasms.

Histologic Type	Age	Sex	Site of Involvement	IDO
Extranodal NK-/T-cell Lymphoma	65	F	Nasal cavity	score 4
	44	M	Nasal cavity	score 4
	26	F	Nasal cavity	score 0
	19	M	Scrotum	score 0
	83	M	Pharynx	score 4
	63	F	Nasal cavity	score 4
	64	M	Soft tissue, hip	score 4
	56	F	Nasal cavity	score 4
	58	M	Nasal cavity	score 4
	76	F	Nasal cavity	score 4
	43	M	Nasal cavity	score 4
	53	M	Nasal cavity	score 4
Primary Cutaneous CD30 positive T-cell Proliferative Disorder
Lymphomatoid Papulosis	42	M	Skin, forearm and thigh	score 4
	57	M	Skin, occipital, and abdomen	score 0
	62	M	Eyelid	score 4
	40	M	Skin, shoulder, and flank	score 1
	62	M	Skin, thigh	score 1
	64	M	Skin, chest	score 1
Primary Cutaneous Anaplastic Large Cell Lymphoma	63	M	Skin, shoulder	score 3
	53	F	Skin, lower leg	score 0
Peripheral T-cell Lymphoma, NOS	78	F	Skin, thigh, and inguinal LN	score 3
	72	M	Axillary LN	score 3
	61	M	Skin, nose	score 1
	74	M	Axillary LN	score 3
	70	F	Cervical LN	score 3
	58	M	Cervical LN	score 3
Anaplastic Large Cell Lymphoma, ALK-positive	14	M	Skin and soft tissue, face	score 3
	21	F	Inguinal LN	score 4
	36	M	Soft tissue and bone, sternum	score 2
Anaplastic Large Cell Lymphoma, ALK-negative	71	M	Sphenoid sinus	score 0
	86	M	Vertebra, lumbar	score 0
Primary Cutaneous CD8-positive Aggressive
Epidermotrophic Cytotoxic T-cell Lymphoma	82	M	Skin, abdomen	score 4
Enteropathy-associated T-cell Lymphoma, Type II	81	F	Small intestine	score 0
Angioimmunoblastic T-cell Lymphoma	55	M	Cervical LN	score 1
Subcutaneous Panniculitis-like T-cell Lymphoma	21	M	Skin, flank	score 4

* ALK: anaplastic lymphoma kinase.